U.S. flag

An official website of the United States government

NM_025136.4(OPA3):c.*1095C>A AND 3-Methylglutaconic aciduria type 3

Clinical significance:Uncertain significance (Last evaluated: Jan 13, 2018)

Review status:1 star out of maximum of 4 stars

criteria provided, single submitter

Based on:
1 submission [Details]
Record status:

Allele description [Variation Report for NM_025136.4(OPA3):c.*1095C>A]


OPA3:outer mitochondrial membrane lipid metabolism regulator OPA3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Genomic location:
Preferred name:
  • NC_000019.10:g.45552419G>T
  • NG_013332.1:g.37446C>A
  • NM_001017989.3:c.143-22963C>A
  • NM_025136.4:c.*1095C>AMANE SELECT
  • NC_000019.9:g.46055677G>T
  • NM_025136.3:c.*1095C>A
dbSNP: rs148228876
NCBI 1000 Genomes Browser:
Molecular consequence:
  • NM_025136.4:c.*1095C>A - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001017989.3:c.143-22963C>A - intron variant - [Sequence Ontology: SO:0001627]


3-Methylglutaconic aciduria type 3 (MGCA3)
OPA3, AUTOSOMAL RECESSIVE; OPTIC ATROPHY 3, AUTOSOMAL RECESSIVE; 3-methylglutaconic aciduria type III; See all synonyms [MedGen]
MONDO: MONDO:0009787; MedGen: C0574084; Orphanet: 67047; OMIM: 258501

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
SCV000413843Illumina Laboratory Services,Illuminacriteria provided, single submitter
Uncertain significance
(Jan 13, 2018)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Illumina Laboratory Services,Illumina, SCV000413843.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided


This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.

OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 23, 2022

Support Center